The emergence of lymphogranuloma venereum in Europe.
Vall-Mayans
Martí
M
STI Unit CAP Drassanes, University Hospital Vall d'Hebron, Catalan Health Institute, Barcelona, Catalonia, Spain. mvall.bcn.ics@gencat.cat
Caballero
Estrella
E
Sanz
Benicio
B
D017088:AIDS-Related Opportunistic Infections / Q000150:complications* / Q000453:epidemiology; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001170:Arthritis, Infectious / Q000382:microbiology*; D002692:Chlamydia trachomatis / Q000235:genetics; D021821:Communicable Diseases, Emerging / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D004269:DNA, Bacterial / Q000032:analysis / Q000235:genetics; D004318:Doxycycline / Q000627:therapeutic use; D005060:Europe / Q000453:epidemiology; D018451:Homosexuality, Male; D006801:Humans; D008219:Lymphogranuloma Venereum / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy / Q000453:epidemiology; D008297:Male; D016133:Polymerase Chain Reaction; D011241:Prednisone / Q000627:therapeutic use; D011349:Proctitis / Q000382:microbiology*; D013582:Synovial Fluid / Q000382:microbiology
D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D004269:DNA, Bacterial; D004318:Doxycycline; D011241:Prednisone